SV

Street Verdict

Analyst Scorecard

A record of what Nagaraj Shetti said publicly, with the source. Not advice.

“Bullish on Natco Pharma for the short-term, recommending a buy at ₹953 with a target of ₹1,010 and a stop loss at ₹925. The stock is attempting an upside breakout from a triangle pattern at ₹955, supported by rising volumes and positive RSI, indicating further short-term upside.”

Nagaraj Shetti’s track record (trackable calls only): 139 graded calls · 95% CI 34–50%

Natco Pharma LtdBullishCalled 03 Jul 2025Graded 16 Jul 2025
Verdict:HIT

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.

Entry: ₹953, as stated.

Target ₹1,010, stop ₹925, as stated.

Window: 30 days, from the call's own horizon word ("for the short-term").

The target ₹1,010 was reached on a close before the stop ₹925. Hit.

The grader’s working: R3 TRADE_SETUP: entered ₹953 on 2025-07-04 (stated entry ₹953, LEVEL_CMP entry, filled); target ₹1010 reached at close ₹1013.05 on 2025-07-16. Window 30 days — rule H4: the quote says "for the short-term" (short-term 30 days, medium-term 90, long-term 12 months).

Tracking Natco Pharma Ltd since this call

1-year tracking window
Read the original articleSee Nagaraj Shetti’s full track record